1. Home
  2. AIRS vs CAII Comparison

AIRS vs CAII Comparison

Compare AIRS & CAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIRS

AirSculpt Technologies Inc.

HOLD

Current Price

$4.67

Market Cap

328.7M

Sector

Health Care

ML Signal

HOLD

CAII

Collective Acquisition Corp. II Class A Ordinary Shares

N/A

Current Price

$9.93

Market Cap

336.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
AIRS
CAII
Founded
2012
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
328.7M
336.3M
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
AIRS
CAII
Price
$4.67
$9.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
449.6K
115.5K
Earning Date
05-12-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$151,818,000.00
N/A
Revenue This Year
$5.19
N/A
Revenue Next Year
$5.32
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.51
$9.90
52 Week High
$12.00
$9.95

Technical Indicators

Market Signals
Indicator
AIRS
CAII
Relative Strength Index (RSI) N/A 50.00
Support Level N/A $9.92
Resistance Level N/A $9.93
Average True Range (ATR) 0.00 0.01
MACD 0.00 0.00
Stochastic Oscillator 0.00 40.00

Price Performance

Historical Comparison
AIRS
CAII

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.

About CAII Collective Acquisition Corp. II Class A Ordinary Shares

Collective Acquisition Corp II is a blank check company.

Share on Social Networks: